Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Crossref DOI link: https://doi.org/10.1038/npp.2017.10
Published Online: 2017-01-16
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ray, Lara A
Bujarski, Spencer
Shoptaw, Steve
Roche, Daniel JO
Heinzerling, Keith
Miotto, Karen
Text and Data Mining valid from 2017-01-16
Article History
Received: 27 March 2016
Revised: 5 January 2017
Accepted: 10 January 2017
First Online: 16 January 2017